Pathophysiology of reversible cerebral vasoconstriction syndrome

被引:0
|
作者
Shih-Pin Chen
Shuu-Jiun Wang
机构
[1] Neurological Institute,Department of Neurology
[2] Taipei Veterans General Hospital,Institute of Clinical Medicine
[3] National Yang Ming Chiao Tung University,Division of Translational Research, Department of Medical Research
[4] Taipei Veterans General Hospital,Brain Research Center & School of Medicine
[5] National Yang Ming Chiao Tung University,undefined
来源
Journal of Biomedical Science | / 29卷
关键词
Reversible cerebral vasoconstriction syndrome; Thunderclap headache; Blood–brain barrier; Neurovascular unit;
D O I
暂无
中图分类号
学科分类号
摘要
Reversible cerebral vasoconstriction syndrome (RCVS) is a complex neurovascular disorder being recognized during the past two decades. It is characterized by multiple abrupt severe headaches and widespread cerebral vasoconstrictions, with potential complications such as ischemic stroke, convexity subarachnoid hemorrhage, intracerebral hemorrhage and posterior reversible encephalopathy syndrome. The clinical features, imaging findings, and dynamic disease course have been delineated. However, the pathophysiology of RCVS remains elusive. Recent studies have had substantial progress in elucidating its pathogenesis. It is now believed that dysfunction of cerebral vascular tone and impairment of blood–brain barrier may play key roles in the pathophysiology of RCVS, which explains some of the clinical and radiological manifestations of RCVS. Some other potentially important elements include genetic predisposition, sympathetic overactivity, endothelial dysfunction, and oxidative stress, although the detailed molecular mechanisms are yet to be identified. In this review, we will summarize what have been revealed in the literature and elaborate how these factors could contribute to the pathophysiology of RCVS.
引用
收藏
相关论文
共 50 条
  • [41] Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review
    Song, T. J.
    Lee, K. H.
    Li, H.
    Kim, J. Y.
    Chang, K.
    Kim, S. H.
    Han, K. H.
    Kim, B. Y.
    Kronbichler, A.
    Ducros, A.
    Koyanagi, A.
    Jacob, L.
    KiM, M. S.
    Yon, D. K.
    Lee, S. W.
    Yang, J. M.
    Hong, S. H.
    Ghayda, R. A.
    Kang, J. W.
    Shin, J., I
    Smith, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (09) : 3519 - 3529
  • [42] Leptomeningeal Carcinomatosis Mimicking Reversible Cerebral Vasoconstriction Syndrome
    Grewal, Parneet
    Hall, Julianne P.
    Dua, Sumeet G.
    Koffman, Lauren
    Dafer, Rima M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [43] Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome
    Topcuoglu, Mehmet Akif
    Chan, Suk-tak
    Silva, Gisele Sampaio
    Smith, Eric Edward
    Kwong, Kenneth K.
    Singhal, Aneesh Bhim
    CEPHALALGIA, 2017, 37 (06) : 541 - 547
  • [44] Hepatic artery vasoconstriction associated with reversible cerebral vasoconstriction syndrome
    Chen, Rong
    Anyanwu, Benjamin
    Feng, Wuwei
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 359 (1-2) : 217 - 218
  • [45] Blood-Brain Barrier Breakdown in Reversible Cerebral Vasoconstriction Syndrome: Implications for Pathophysiology and Diagnosis
    Lee, Mi Ji
    Cha, Jihoon
    Choi, Hyun Ah
    Woo, Sook-Young
    Kim, Seonwoo
    Wang, Shuu-Jiun
    Chung, Chin-Sang
    ANNALS OF NEUROLOGY, 2017, 81 (03) : 454 - 466
  • [46] Recurrent reversible cerebral vasoconstriction syndrome and antiphospholipid syndrome
    Sowanou, Arlos
    Ungureanu, Aurelian
    Aguesse, Claire
    ACTA NEUROLOGICA BELGICA, 2024, 124 (01) : 329 - 334
  • [47] Recurrent reversible cerebral vasoconstriction syndrome and antiphospholipid syndrome
    Arlos Sowanou
    Aurelian Ungureanu
    Claire Aguesse
    Acta Neurologica Belgica, 2024, 124 : 329 - 334
  • [48] Illicit Drugs and Reversible Cerebral Vasoconstriction Syndrome
    Short, Katherine
    Emsley, Hedley C. A.
    NEUROHOSPITALIST, 2021, 11 (01) : 40 - 44
  • [49] Reversible cerebral vasoconstriction syndrome triggered by ondansetron
    della Faille, Laetitia
    Claesen, Evelien
    Cappelle, Sarah
    Lemmens, Robin
    ACTA NEUROLOGICA BELGICA, 2021, 121 (04) : 1061 - 1063
  • [50] Cyproheptadine in the treatment of reversible cerebral vasoconstriction syndrome
    Jennifer Chima
    Naresh Mullaguri
    Tracey Fan
    Pravin George
    Christopher R. Newey
    Acta Neurologica Belgica, 2021, 121 : 1871 - 1874